Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghady Haidar

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Intensive Care Medicine Experimental|February 3, 2026
Microbial lung-to-blood translocation associates with systemic inflammation in severe pneumonia: evidence from paired plasma and lower respiratory tract metagenomicsHaopu Yang, Matthew K Hensley, Vi D-B Nguyen, et al.
Open Forum Infectious Diseases|June 2, 2023
Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody TherapyJana L Jacobs, Ghady Haidar, Asma Naqvi, et al.
The Lancet. Infectious Diseases|February 27, 2025
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trialGhady Haidar, Steven Thomas, Paul Loubet, et al.
Open Forum Infectious Diseases|July 12, 2021
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJ Ryan Bariola, Erin K McCreary, Richard J Wadas, et al.
Iscience|November 15, 2023
Noninvasive diagnosis of secondary infections in COVID-19 by sequencing of plasma microbial cell-free DNAGrace Lisius, Radha Duttagupta, Asim A Ahmed, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2025
Increased rate of deceased donor liver transplantation for candidates willing to receive organs from donors with human immunodeficiency virusZeba Nauroz, Sander Florman, Meenakshi M Rana, et al.
Contemporary Clinical Trials|December 13, 2021
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 daysErin K McCreary, J Ryan Bariola, Tami Minnier, et al.
Transplantation|November 17, 2025
APOL1 Genotype and Patient Outcomes in US and South African Transplant Recipients With HIV who Received Kidneys From Donors With HIVRobert Freercks, Moreno Rodrigues, Kathryn Manning, et al.
The Journal of Infectious Diseases|November 16, 2023
Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised IndividualsGhady Haidar, Jacob C Hodges, Andrew Bilderback, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
<i>APOL1</i> genotype and patient outcomes in US and South African transplant recipients with HIV who received kidneys from donors with HIVRobert Freercks, Moreno Rodrigues, Kathryn Manning, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Intensive Care Medicine Experimental|February 3, 2026
Microbial lung-to-blood translocation associates with systemic inflammation in severe pneumonia: evidence from paired plasma and lower respiratory tract metagenomicsHaopu Yang, Matthew K Hensley, Vi D-B Nguyen, et al.
Open Forum Infectious Diseases|June 2, 2023
Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody TherapyJana L Jacobs, Ghady Haidar, Asma Naqvi, et al.
The Lancet. Infectious Diseases|February 27, 2025
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trialGhady Haidar, Steven Thomas, Paul Loubet, et al.
Open Forum Infectious Diseases|July 12, 2021
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJ Ryan Bariola, Erin K McCreary, Richard J Wadas, et al.
Iscience|November 15, 2023
Noninvasive diagnosis of secondary infections in COVID-19 by sequencing of plasma microbial cell-free DNAGrace Lisius, Radha Duttagupta, Asim A Ahmed, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2025
Increased rate of deceased donor liver transplantation for candidates willing to receive organs from donors with human immunodeficiency virusZeba Nauroz, Sander Florman, Meenakshi M Rana, et al.
Contemporary Clinical Trials|December 13, 2021
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 daysErin K McCreary, J Ryan Bariola, Tami Minnier, et al.
Transplantation|November 17, 2025
APOL1 Genotype and Patient Outcomes in US and South African Transplant Recipients With HIV who Received Kidneys From Donors With HIVRobert Freercks, Moreno Rodrigues, Kathryn Manning, et al.
The Journal of Infectious Diseases|November 16, 2023
Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised IndividualsGhady Haidar, Jacob C Hodges, Andrew Bilderback, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
<i>APOL1</i> genotype and patient outcomes in US and South African transplant recipients with HIV who received kidneys from donors with HIVRobert Freercks, Moreno Rodrigues, Kathryn Manning, et al.
Pageof 10